Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Behavioral disorders in Parkinson's disease: from pathophysiology to the mastery of dopaminergic treatment].
Thobois S, Ardouin C, Schmitt E, Lhommée E, Klinger H, Xie J, Lagrange C, Kistner A, Aya Kombo M, Fleury V, Poisson A, Fraix V, Broussolle E, Pollak P, Krack P. Thobois S, et al. Among authors: schmitt e. Rev Neurol (Paris). 2010 Oct;166(10):816-21. doi: 10.1016/j.neurol.2010.07.006. Epub 2010 Aug 23. Rev Neurol (Paris). 2010. PMID: 20739041 Review. French.
Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
Lhommée E, Klinger H, Thobois S, Schmitt E, Ardouin C, Bichon A, Kistner A, Fraix V, Xie J, Aya Kombo M, Chabardès S, Seigneuret E, Benabid AL, Mertens P, Polo G, Carnicella S, Quesada JL, Bosson JL, Broussolle E, Pollak P, Krack P. Lhommée E, et al. Among authors: schmitt e. Brain. 2012 May;135(Pt 5):1463-77. doi: 10.1093/brain/aws078. Epub 2012 Apr 15. Brain. 2012. PMID: 22508959
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.
Moreau C, Delval A, Defebvre L, Dujardin K, Duhamel A, Petyt G, Vuillaume I, Corvol JC, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Sablonniere B, Azulay JP, Tison F, Rascol O, Vidailhet M, Destée A, Bloem BR, Bordet R, Devos D; Parkgait-II study group. Moreau C, et al. Lancet Neurol. 2012 Jul;11(7):589-96. doi: 10.1016/S1474-4422(12)70106-0. Epub 2012 Jun 1. Lancet Neurol. 2012. PMID: 22658702 Clinical Trial.
Psychostimulant effect of levodopa: reversing sensitisation is possible.
Castrioto A, Kistner A, Klinger H, Lhommée E, Schmitt E, Fraix V, Chabardès S, Mertens P, Quesada JL, Broussolle E, Pollak P, Thobois SC, Krack P. Castrioto A, et al. Among authors: schmitt e. J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):18-22. doi: 10.1136/jnnp-2012-302444. Epub 2012 Sep 18. J Neurol Neurosurg Psychiatry. 2013. PMID: 22991345 Clinical Trial.
Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.
Thobois S, Lhommée E, Klinger H, Ardouin C, Schmitt E, Bichon A, Kistner A, Castrioto A, Xie J, Fraix V, Pelissier P, Chabardes S, Mertens P, Quesada JL, Bosson JL, Pollak P, Broussolle E, Krack P. Thobois S, et al. Among authors: schmitt e. Brain. 2013 May;136(Pt 5):1568-77. doi: 10.1093/brain/awt067. Epub 2013 Mar 29. Brain. 2013. PMID: 23543483 Clinical Trial.
Dopaminergic modulation of emotional conflict in Parkinson's disease.
Fleury V, Cousin E, Czernecki V, Schmitt E, Lhommée E, Poncet A, Fraix V, Troprès I, Pollak P, Krainik A, Krack P. Fleury V, et al. Among authors: schmitt e. Front Aging Neurosci. 2014 Jul 23;6:164. doi: 10.3389/fnagi.2014.00164. eCollection 2014. Front Aging Neurosci. 2014. PMID: 25100991 Free PMC article.
Disentangling the Role of Cortico-Basal Ganglia Loops in Top-Down and Bottom-Up Visual Attention: An Investigation of Attention Deficits in Parkinson Disease.
Tommasi G, Fiorio M, Yelnik J, Krack P, Sala F, Schmitt E, Fraix V, Bertolasi L, Le Bas JF, Ricciardi GK, Fiaschi A, Theeuwes J, Pollak P, Chelazzi L. Tommasi G, et al. Among authors: schmitt e. J Cogn Neurosci. 2015 Jun;27(6):1215-37. doi: 10.1162/jocn_a_00770. Epub 2014 Dec 16. J Cogn Neurosci. 2015. PMID: 25514652
Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.
Moreau C, Meguig S, Corvol JC, Labreuche J, Vasseur F, Duhamel A, Delval A, Bardyn T, Devedjian JC, Rouaix N, Petyt G, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Azulay JP, Tison F, Destée A, Vidailhet M, Rascol O, Dujardin K, Defebvre L, Bordet R, Sablonnière B, Devos D; Parkgait-II Study Group. Moreau C, et al. Brain. 2015 May;138(Pt 5):1271-83. doi: 10.1093/brain/awv063. Epub 2015 Mar 23. Brain. 2015. PMID: 25805645 Free PMC article. Clinical Trial.
Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease.
Martinez-Fernandez R, Pelissier P, Quesada JL, Klinger H, Lhommée E, Schmitt E, Fraix V, Chabardes S, Mertens P, Castrioto A, Kistner A, Broussolle E, Pollak P, Thobois S, Krack P. Martinez-Fernandez R, et al. Among authors: schmitt e. J Neurol Neurosurg Psychiatry. 2016 Mar;87(3):311-8. doi: 10.1136/jnnp-2014-310189. Epub 2015 Apr 30. J Neurol Neurosurg Psychiatry. 2016. PMID: 25934016
1,262 results